Peptides Studied in Tissue Recovery Research: A Review of the Evidence

Overview

Several synthetic peptides have been studied extensively in preclinical models of tissue injury and recovery. This article reviews the published evidence for the most studied compounds in this category. All information is drawn from peer-reviewed research and is provided for research reference only.

BPC-157 (Body Protection Compound 157)

BPC-157 is among the most studied peptides in tissue repair research, with over 100 published animal studies. Its research applications span:

- Tendon and ligament repair: Multiple studies in rodent models demonstrate accelerated tendon healing, improved tensile strength, and promotion of tendon cell outgrowth [1] - Muscle repair: Studies in muscle crush injury models show improved recovery and reduced fibrosis - Gastrointestinal healing: Strong evidence in models of gastric ulcer, inflammatory bowel disease, and short bowel syndrome - Bone repair: Studies in bone defect models show improved healing

The 2025 systematic review by Vasireddi et al. in Current Reviews in Musculoskeletal Medicine identified 47 animal studies with consistent positive findings in musculoskeletal models [2].

TB-500 (Thymosin Beta-4 Fragment)

TB-500 / Thymosin Beta-4 has been studied in:

- Wound healing: Topical Tβ4 accelerates wound closure in multiple animal models through promotion of cell migration and angiogenesis [3] - Cardiac repair: Tβ4 has shown cardioprotective effects in rodent myocardial infarction models, promoting cardiomyocyte survival and angiogenesis [4] - Tendon repair: Studies in equine and rodent tendon injury models show improved healing - Neurological recovery: Studies in stroke and traumatic brain injury models show neuroprotective effects

GHK-Cu (Copper Peptide)

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding peptide found in human plasma, saliva, and urine. It has been studied in:

- Wound healing: GHK-Cu promotes fibroblast proliferation, collagen synthesis, and angiogenesis in wound models [5] - Skin repair: Extensive research on GHK-Cu's role in skin remodeling and repair - Anti-inflammatory effects: GHK-Cu modulates inflammatory cytokine expression in several models

GHK-Cu has a strong published evidence base in wound healing, with research dating back to the 1970s.

Semax

Semax is a synthetic heptapeptide analogue of ACTH(4-10) that has been studied primarily in neurological recovery models:

- Stroke recovery: Russian clinical studies have examined Semax in ischemic stroke, with some evidence of improved neurological outcomes [6] - Neuroprotection: Animal studies demonstrate neuroprotective effects in models of brain ischemia - Cognitive function: Studies in rodent models show effects on memory and learning

Semax has a more developed clinical evidence base than most research peptides, due to its use in Russian medicine.

Selank

Selank is a synthetic analogue of tuftsin (a naturally occurring tetrapeptide) that has been studied in anxiety and stress models:

- Anxiolytic effects: Animal studies demonstrate anxiolytic activity comparable to benzodiazepines without sedation - Cognitive effects: Studies show effects on memory consolidation and learning in rodent models - Anti-inflammatory: Modulation of cytokine expression in several models

Summary Table

| Peptide | Primary Research Area | Evidence Level | |---|---|---| | BPC-157 | Musculoskeletal, GI repair | Strong (animal models) | | TB-500 / Tβ4 | Wound healing, cardiac repair | Strong (animal + some clinical) | | GHK-Cu | Wound healing, skin repair | Strong (animal + in vitro) | | Semax | Neurological recovery | Moderate (animal + limited clinical) | | Selank | Anxiety, cognitive function | Moderate (animal models) |

For research use only. Not for human or animal consumption.

References

1. Chang, C.H., et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing. Journal of Applied Physiology, 110(3), 774–780.
2. Vasireddi, N., et al. (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine. Current Reviews in Musculoskeletal Medicine, 18(1), 1–10.
3. Philp, D., & Kleinman, H.K. (2010). Animal studies with thymosin beta. Annals of the New York Academy of Sciences, 1194, 81–86.
4. Bock-Marquette, I., et al. (2004). Thymosin beta4 activates integrin-linked kinase. Nature, 432(7016), 466–472.
5. Pickart, L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987.
6. Dolotov, O.V., et al. (2006). Semax, an analogue of ACTH(4-7), regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54–60.